Skip to content
Search

Latest Stories

Thornton & Ross donates over 100K free skincare samples to NHS frontline workers

Thornton & Ross has donated over 100 thousand free skincare samples to healthcare professionals throughout the UK from two of its leading skincare ranges - Cetraben and Zeroderma.

To support NHS frontline workers, the Yorkshire-based pharmaceutical manufacturer will continue to donate the emollients, which minimise the discomfort of irritated skin caused by prolonged use of facemasks, frequent hand washing and increased hand sanitizing, the company said on Wednesday (June 3).


Emma Kovaleski, Fundraising Manager of the Calderdale and Huddersfield NHS Charity said: “The skincare samples have not only put a smile on the faces of my colleagues as they continue to face huge pressures as a result of the coronavirus pandemic, but have helped to soothe some very sore, cracked hands. We’re all hugely grateful to the Thornton & Ross team for helping to keep us comfortable at this challenging time.”

Cetraben is the first eczema-prone skincare range to be approved by the British Skin Foundation.

Zeroderma is one of the skincare ranges available on prescription in the UK.

Roger Scarlett Smith, T&R’s Executive Vice President said: “I couldn’t be prouder of my colleagues at Thornton & Ross, for their enthusiasm in driving forward this initiative to support healthcare professionals up and down the country.

“From order processing all the way through to delivery, it’s been a huge team effort and it is fantastic to see over 100,000 samples of the emollients have now made it to the hands and faces of our NHS frontline heroes.”

The manufacturer has also provided 14,000 bottles of its leading disinfectant, Zoflora to help staff at local hospitals eliminate bacteria and viruses on door handles and cars before driving home at the end of each shift.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less